CN101850046A - Chinese medicament for treating chronic hepatitis - Google Patents
Chinese medicament for treating chronic hepatitis Download PDFInfo
- Publication number
- CN101850046A CN101850046A CN200910242161A CN200910242161A CN101850046A CN 101850046 A CN101850046 A CN 101850046A CN 200910242161 A CN200910242161 A CN 200910242161A CN 200910242161 A CN200910242161 A CN 200910242161A CN 101850046 A CN101850046 A CN 101850046A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- radix
- chinese medicine
- chronic hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic hepatitis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as rhizoma bistortae, radix pseudo-ginseng, Chinese angelica, radix rehmanniae, glossy ganoderma, green tangerine peel, sappan wood and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, clearing heat and detoxicating, inducing diuresis and reducing edema, promoting blood circulation by removing blood stasis and stopping pain, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function descend, hepatic fibrosis is serious etc., patient's life quality descends, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Paridis 5---30 parts of 40 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---
The Radix Rehmanniae 4---30 parts of 30 portions of Ganodermas 2---12 parts of Pericarpium Citri Reticulatae Virides 4---
Lignum Sappan 3---20 parts
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Paridis, Radix Angelicae Sinensis, the Radix Rehmanniae, Pericarpium Citri Reticulatae Viride, Lignum Sappan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We reuse the Rhizoma Paridis heat-clearing and toxic substances removing, and are inducing diuresis and reducing edema; Close with Pericarpium Citri Reticulatae Viride and go into the liver and gall warp, can soothing the liver dispelling the stagnated QI, rush down pain relieving clearly, anti-again grass and car bitter cold are too; Be aided with Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng, Lignum Sappan promoting blood circulation, removing blood stasis and relieving pain, the enhance liver microcirculation.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, and heat-clearing and toxic substances removing is inducing diuresis and reducing edema, and the merit of promoting blood circulation, removing blood stasis and relieving pain is effective, instant effect, and it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Rhizoma Paridis 100 gram Radix Notoginseng 60 gram Radix Angelicae Sinensis 80 grams
The Radix Rehmanniae 80 kairine sesames 40 gram Pericarpium Citri Reticulatae Virides 80 grams
Lignum Sappan 60 grams
Weight in accordance with regulations, with conventional water extraction process Rhizoma Paridis, Radix Angelicae Sinensis, the Radix Rehmanniae, Pericarpium Citri Reticulatae Viride, Lignum Sappan are extracted, make extractum fine powder 120 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Rhizoma Paridis 200 gram Radix Notoginseng 90 gram Radix Angelicae Sinensis 160 grams
The Radix Rehmanniae 160 kairine sesames 60 gram Pericarpium Citri Reticulatae Virides 160 grams
Lignum Sappan 90 grams
By above-mentioned same method, make 1360 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Rhizoma Paridis 400 gram Radix Notoginseng 200 gram Radix Angelicae Sinensis 300 grams
The Radix Rehmanniae 300 kairine sesames 120 gram Pericarpium Citri Reticulatae Virides 300 grams
Lignum Sappan 200 grams
By above-mentioned same method, make 2750 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 4 parts of Radix Angelicae Sinensis of 9 portions of Radix Notoginseng of Rhizoma Paridis
7 parts on 3 parts of Pericarpium Citri Reticulatae Virides of 7 portions of Ganodermas of the Radix Rehmanniae
4 parts of Lignum Sappans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 15 parts of Radix Angelicae Sinensis of 35 portions of Radix Notoginseng of Rhizoma Paridis
25 parts on 8 parts of Pericarpium Citri Reticulatae Virides of 25 portions of Ganodermas of the Radix Rehmanniae
15 parts of Lignum Sappans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 7 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are defective.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 44 years old-71 years old, 60.7 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is alleviated obviously; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. a Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Paridis 5---30 parts of 40 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---
The Radix Rehmanniae 4---30 parts of 30 portions of Ganodermas 2---12 parts of Pericarpium Citri Reticulatae Virides 4---
Lignum Sappan 3---20 parts
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Paridis, Radix Angelicae Sinensis, the Radix Rehmanniae, Pericarpium Citri Reticulatae Viride, Lignum Sappan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421610A CN101850046B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421610A CN101850046B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850046A true CN101850046A (en) | 2010-10-06 |
| CN101850046B CN101850046B (en) | 2011-07-27 |
Family
ID=42801836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102421610A Expired - Fee Related CN101850046B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850046B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101979006A (en) * | 2010-10-27 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1044974C (en) * | 1994-06-17 | 1999-09-08 | 殷广全 | Anti- hepatitis B preparation |
| CN1063954C (en) * | 1997-04-03 | 2001-04-04 | 周道红 | Chinese patent medicine-powder preparation for curing hepatitis B |
-
2009
- 2009-12-09 CN CN2009102421610A patent/CN101850046B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101979006A (en) * | 2010-10-27 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850046B (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843704B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843709B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843775A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101874870B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843679A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850021A (en) | Chinese medicament for treating abnormal menstruation | |
| CN101850036A (en) | Chinese medicament for treating chronic hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SUZHOU DANFANG TEXTILE RESEARCH + DEVELOPMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150104 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 215228 SUZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150104 Address after: 215228 Jiangsu City, Wujiang Province, Shengze Town, No. two West Ring Road, No. Shengze Textile Science and Technology Park, building 10, 1188 Patentee after: Suzhou Danfang Textile Research & Development Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 Termination date: 20181209 |